Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Medpace Sweden AB
AB
Active
Org 5567250385
Stockholm
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2007 · 19 years old
39 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Medpace Sweden AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
66M
50M
33M
17M
0M
2021: 25M
25M
2021
2022: 37M (+48% vs 2021)
37M
+48%
2022
2023: 42M (+14% vs 2022)
42M
+14%
2023
2024: 43M (+2% vs 2023)
43M
+2%
2024
2025: 53M (+23% vs 2024)
53M
+23%
2025
EBITDA
SEK millions
4M
3M
2M
1M
0M
2021: 1M
1M
2021
2022: 2M (+100% vs 2021)
2M
+100%
2022
2023: 2M (0% vs 2022)
2M
0%
2023
2024: 3M (+50% vs 2023)
3M
+50%
2024
2025: 3M (0% vs 2024)
3M
0%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
53 094
43 392
42 096
36 747
25 425
Staff expenses
−45 089
—
—
—
—
EBITDA
3 256
2 540
2 353
1 648
1 155
Depreciation & amort.
−132
−125
−74
−87
−116
EBIT
3 124
2 415
2 279
1 561
1 039
Net financials
124
1
−139
−6
14
Profit before tax
3 248
2 416
2 141
1 555
1 053
Tax
−656
−508
−440
−323
−218
Net profit
2 592
1 908
1 701
1 232
835
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
16 015
12 698
10 833
9 162
8 034
Equity
11 196
8 604
6 696
4 995
3 763
Long-term debt
—
0
0
0
0
Short-term debt
4 819
4 094
4 137
4 167
4 271
Total debt
4 819
4 094
4 137
4 167
4 271
Financial ratios
5-year trend
EBITDA margin
6,1 %
This company
15,8 %
Market median
This company
Market median
61% below market
2021
2025
Equity ratio
69,9 %
This company
38,2 %
Market median
This company
Market median
83% above market
2021
2025
Return on equity
23,2 %
This company
18,4 %
Market median
This company
Market median
26% above market
2021
2025
Net profit margin
4,9 %
This company
8,1 %
Market median
This company
Market median
40% below market
2021
2025
Asset turnover
3,32×
This company
1,12×
Market median
This company
Market median
196% above market
2021
2025
Debt / equity
0,43×
This company
0,62×
Market median
This company
Market median
31% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Medpace Sweden AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
